Biblio Discovery — Demo Discovery Service

18 results for "Shaoyan Lin"

Showing 1–18 · 1.66 seconds · RSS

  1. Journal Article

    Comprehensive analysis of the metabolic nutritional components and exploration of health‐promoting small molecules in japonica rice and indica rice seeds

    Mengjun Tian; Shaoyan Lin; Wenwen Huang et al.

    Food Safety and Health, Vol. 2 No. 3 · 2024 · English · DOAJ Scopus

    Abstract The comprehensive detection of primary metabolites and secondary metabolites in japonica rice (Nipponbare) and indica rice seeds (93‐11) were clarified by using a combination of targeted and untargeted metabolomics approaches we created. A total of 246 metabolites were identified…

  2. Journal Article

    Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population

    Shaoyan Lin; Hongnan Mo; Yiqun Li et al.

    BMC Cancer, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background We investigated the clinicopathological characteristics and survival of breast cancer lung metastases (BCLM) patients at initial diagnosis of metastatic breast cancer (MBC) in the Han population. Methods We attained clinical data of 3155 MBC patients initially diagnosed between…

  3. Journal Article

    Efficacy of transcutaneous electrical acupoint stimulation for the treatment of gastrointestinal dysfunction in patients after cardiac surgery with cardiopulmonary bypass: study protocol for a superiority, single-centre, single-blind, randomised controlled clinical trial

    Jing Wang; Hui Li; Yanxian Chen et al.

    BMJ Open, Vol. 15 No. 11 · 2025 · English · DOAJ Scopus

    Objective Gastrointestinal dysfunction is one of the most frequent complications in patients after cardiac surgery with cardiopulmonary bypass (CPB). It can seriously affect the patient’s quality of life, increase the length of hospitalisation and in severe cases trigger cardiac arrest. This…

  4. Journal Article

    Protective Effects of MicroRNA‐200b‐3p Encapsulated by Mesenchymal Stem Cells–Secreted Extracellular Vesicles in Myocardial Infarction Via Regulating BCL2L11

    Jun Wan; Shaoyan Lin; Zhuo Yu et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 11 No. 12 · 2022 · English · DOAJ Scopus

    Background Extracellular vesicles (EVs) are a popular treatment candidate for myocardial injury. This work investigated the effects of mesenchymal stem cells (MSCs)–secreted EVs–derived miR‐200b‐3p on cardiomyocyte apoptosis and inflammatory response after myocardial infarction (MI) through…

  5. Journal Article

    A Novel Rat Model of Cardiac Donation After Circulatory Death Combined With Normothermic ex situ Heart Perfusion

    Jiale Li; Chuqing Xue; Xiao Ling et al.

    Frontiers in Cardiovascular Medicine, Vol. 8 · 2021 · English · DOAJ Scopus

    Background: In heart transplantation, the adoption of hearts from donation after circulatory death (DCD) is considered to be a promising approach to expanding the donor pool. Normothermic ex situ heart perfusion (ESHP) is emerging as a novel preservation strategy for DCD hearts. Therefore…

  6. Journal Article

    Normothermic ex vivo heart perfusion with NLRP3 inflammasome inhibitor Mcc950 treatment improves cardiac function of circulatory death hearts after transplantation

    Liwei Xu; Zifeng Zeng; Chuanjie Niu et al.

    Frontiers in Cardiovascular Medicine, Vol. 10 · 2023 · English · DOAJ Scopus

    BackgroundThe utilization of donation after circulatory death (DCD) hearts can enlarge the donor pool. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies found that the activation of NLRP3 inflammasome could play a significant role in organ IRI. Mcc950, which…

  7. Journal Article

    Normothermic ex vivo Heart Perfusion Combined With Melatonin Enhances Myocardial Protection in Rat Donation After Circulatory Death Hearts via Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis

    Jun Lu; Liwei Xu; Zifeng Zeng et al.

    Frontiers in Cell and Developmental Biology, Vol. 9 · 2021 · English · DOAJ Scopus

    ObjectiveThe adoption of hearts from donation after circulatory death (DCD) is a promising approach for the shortage of suitable organs in heart transplantation. However, DCD hearts suffer from serious ischemia/reperfusion injury (IRI). Recent studies demonstrate that nucleotide-binding…

  8. Journal Article

    Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy

    Shaoyan Lin; Huaqiang Zhou; Gang Chen et al.

    BMC Cancer, Vol. 24 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Purpose Patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) have proven benefit from anti-programmed cell death 1 (anti-PD-1) monotherapy. Here, we retrospectively analyze the association of plasma Epstein-Barr virus (EBV) DNA load and tumor viral lytic genome with…

  9. Journal Article Full text

    Heterologous Expression of Sunflower HaHPT and HaTMT Genes Enhances Rice-Grain Vitamin E Content

    Shuang Song; Hang Li; Shaoyan Lin et al.

    Plants, Vol. 13 No. 17 · 2024 · English · DOAJ Scopus

    Insufficient dietary vitamin intake can lead to severe health conditions in humans. Improving the vitamin E (VE) content of food crops such as rice through breeding is an economical and effective means to alleviate this problem. In this study, Homogentisate phytyltransferase (HPT) and γ-tocopherol…

  10. Journal Article

    Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

    Shaoyan Lin; Jian Yue; Xiuwen Guan et al.

    Cancer Communications, Vol. 39 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Breast cancer is a global problem, and a large number of new cases are diagnosed every year. Capecitabine is effective in patients with metastatic breast cancer (MBC). Hand-foot syndrome (HFS) is a common adverse effect of capecitabine. In this study, we investigated the…

  11. Journal Article

    Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China

    Yiqun Li; Hongnan Mo; Xiuwen Guan et al.

    Breast, Vol. 61 · 2022 · English · DOAJ Scopus

    Background: To observe whether guideline non-adherence in initial palliative treatment choices for premenopausal hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) patients result in worse clinical outcomes in the Chinese population. Methods: The China National Cancer…

  12. Journal Article

    Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population

    Shaoyan Lin; Hongnan Mo; Yiqun Li et al.

    Frontiers in Oncology, Vol. 11 · 2021 · English · DOAJ Scopus

    The risk factors for morbidity and mortality in patients with breast cancer liver metastases (BCLM) upon initial metastatic breast cancer (MBC) diagnosis have not been adequately identified in Han population. Data of 3,161 female patients who were initially diagnosed with MBC from December 1991 to…

  13. Journal Article

    Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China

    Shaoyan Lin; Hongnan Mo; Yiqun Li et al.

    Breast, Vol. 53 · 2020 · English · DOAJ Scopus

    Background: There is a lack of prognostic models predicting the overall survival (OS) of advanced breast cancer (ABC) patients in China. Methods: Data from the China National Cancer Center database that recorded 4039 patients diagnosed with breast cancer between 1987 and 2019 were extracted and a…

  14. Journal Article

    In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

    Yiqun Li; Nilupai Abudureheiyimu; Hongnan Mo et al.

    Frontiers in Oncology, Vol. 11 · 2022 · English · DOAJ Scopus

    BackgroundTo characterize the clinical and pathological features and survival of patients with human epidermal growth factor receptor 2 (HER2)-low breast cancer in China.MethodsThe China National Cancer Center database was used to identify 1,433 metastatic breast cancer patients with HER2-negative…

  15. Journal Article

    Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China

    Yiqun Li; Qiao Li; Hongnan Mo et al.

    Breast, Vol. 55 · 2021 · English · DOAJ Scopus

    Purpose: To characterize the incidence, risk factors and survival of patients with brain metastases at initial diagnosis of metastatic breast cancer (MBC) in China. Methods: The China National Cancer Center database was used to identify 2087 MBC patients diagnosed between 2003 and 2015…

  16. Journal Article

    Phase 1b/2 study of ADG106, a 4-1BB/CD137 agonist, in combination with toripalimab in patients with advanced solid tumors

    Shaoyan Lin; Yuxiang Ma; Yongsheng Wang et al.

    iScience, Vol. 28 No. 5 · 2025 · English · DOAJ Scopus

    Summary: This phase 1b/2 clinical trial (NCT04775680) evaluated the safety, efficacy, pharmacokinetics and pharmacodynamics of ADG106, a ligand-blocking agonistic antibody targeting CD137 (4-1BB), combined with toripalimab in patients with advanced malignancies. ADG106 0.75–3 mg/kg plus toripalimab…

  17. Journal Article

    Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors—A phase 1/1b study

    Yuxiang Ma; Shaoyan Lin; Qun Chen et al.

    Cell Reports Medicine, Vol. 6 No. 10 · 2025 · English · DOAJ Scopus

    Summary: QL1706 has shown promising efficacy in solid tumors in a phase 1/1b study. Here, we report updated long-term survival outcomes and biomarker analyses. Among 468 patients treated with QL1706 (5 mg/kg), median progression-free survival (mPFS) and overall survival (mOS) are 1.5 and 14.2…